COMP <GO>
INM vs CURX // ENTERPRISE SCALE & MARKET CAP
InMed Pharmaceuticals Inc. (NASDAQ) VS. Curanex Pharmaceuticals Inc (NASDAQ) • 15-METRIC TALLY: INM 2
— CURX 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: CURX
LAST: $1.68 (+3.07%) • MKT CAP: $9.0M
market-cap
$9.0M
LAST: $6.19 (+5.81%) • MKT CAP: $9.2M
market-cap
$9.2M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INM VS. CURX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INM | CURX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 34.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 7.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 1/9 | +3.00 | INM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.2 | 65.3 | +3.90 | INM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $9.0M | $9.2M | -$219.4K | CURX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INM REV | CURX REV | INM GROSS % | CURX GROSS % | INM FCF | CURX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.9M | $11.9M | 34.5% | — | -$8.1M | -$10.5M |
| FY 2024 | $4.6M | $1.0M | 23.9% | — | -$7.0M | -$555.6K |
| FY 2023 | $4.1M | — | — | — | -$7.3M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INM // BETA —
CURX // BETA —